MCRB - Seres Therapeutics, Inc.

8.09
-0.350   -4.326%

Share volume: 44,600
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%
$8.44
-0.35
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-13-2024 11-13-2024 03-13-2025 05-07-2025 08-06-2025 11-05-2025 03-12-2026
Total revenue 0.000 0.000 0.000 0.000 0.000 0.000 351.000 K 438.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 0.000 0.000 0.000 0.000 0.000 0.000 351.000 K 438.000 K
    nan% nan% nan%   nan% inf% 24.79%  
Operating expenses 37.168 M 33.934 M 29.170 M 17.511 M 23.709 M 23.192 M 22.092 M 19.223 M
Selling general and admin 15.466 M 16.059 M 12.710 M 8.948 M 11.888 M 10.253 M 9.476 M 7.539 M
Research and development 21.702 M 17.875 M 16.460 M 8.563 M 11.821 M 12.939 M 12.616 M 11.684 M
Total expenses 39.586 M 31.345 M 29.170 M 21.214 M 27.236 M 24.881 M 22.828 M 19.815 M
    -20.82% -6.94% -27.27% 28.39% -8.65% -8.25% -13.20%  
Operating income -39.586 M -31.345 M -29.170 M -21.214 M -27.236 M -24.881 M -22.477 M -19.377 M
Ebit -37.118 M -30.653 M -51.687 M -10.280 M 32.064 M -20.401 M 7.586 M -15.780 M
Pretax income -40.133 M -32.870 M -51.035 M -1.733 M 32.682 M -19.855 M 8.204 M -15.335 M
    -18.10% 55.26% -96.60% -1,985.86% -160.75% -141.32% -286.92%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -40.133 M -32.870 M 88.776 M -15.637 M 32.682 M -19.855 M 8.204 M -15.335 M
    18.10% 370.08% -117.61% 309.00% -160.75% 141.32% -286.92%